Part Used : ใบ
Activity : DRUG INTERACTION
Solvent/Active Compound : Extract of Ginkgo biloba (Egb761)
Type of experiment : human
Type of animal : -
Type of study : Open trial
N(Total) : 60*
N(Treatment) : -
Route : Oral administration
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : Doxorubicin*/Adrimycin/ADR/Adria
Dose/Conc.(drug) : -
Note : *Sixty breast cancer patients in stage IV were randomly assigned to two groups, the control group was treated with chemotherepy, using 4 cycles of PA protocol alone and the treated group with the same chemotherapy and Egb761. Egb761 prevented and reduced the acute doxorubicin-induced cardiotoxicity and could helpful for alleviating the chronic cardiotoxicity.
- Data incomplete.